Study guide
Section 2.5: Pharmacognosy: Natural Products & Dietary Supplements
Saudi Pharmacist Licensure Examination SPLE - Pharmacist
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
Section 0.1: About the Saudi Pharmacist Licensure Examination (SPLE) Section 0.2: How to Study and Prep for the SPLE
2 Chapter 1: Basic Biomedical Sciences
Section 1.1: Human Physiology & Pathophysiology Foundations Section 1.2: Medical Biochemistry & Enzymology Section 1.3: Medical Microbiology & Immunology Section 1.4: Molecular Genetics & Pharmacogenomics Foundations
3 Chapter 2: Pharmaceutical Sciences
Section 2.1: Medicinal Chemistry & Structure-Activity Relationships (SAR) Section 2.2: Drug ADME (Absorption, Distribution, Metabolism, Excretion) Section 2.3: General Pharmacology: Mechanisms of Drug Action Section 2.4: General Toxicology: Overdose, Antidotes & Adverse Drug Reactions (ADRs) Section 2.5: Pharmacognosy: Natural Products & Dietary Supplements Section 2.6: Basic Pharmaceutics & Dosage Form Design Section 2.7: Biopharmaceutics & Drug Delivery Systems Section 2.8: Applied Pharmacokinetics (PK): One-Compartment Models Section 2.9: Non-linear and Multi-compartment Pharmacokinetics Section 2.10: Sterile Compounding: Techniques & Quality Standards Section 2.11: Non-sterile Compounding & Product Formulation Section 2.12: Pharmaceutical Calculations: Dosing and Strengths Section 2.13: Pharmaceutical Calculations: Dilutions and Reconstitution Section 2.14: Pharmaceutical Calculations: Osmolarity, Milliequivalents, and Alligations
4 Chapter 3: Social, Behavioral, and Administrative Sciences
Section 3.1: Saudi Arabian Healthcare System & Public Health Policies Section 3.2: Pharmacoepidemiology & Post-Marketing Drug Surveillance Section 3.3: Pharmacovigilance & Drug Safety Monitoring in Saudi Arabia Section 3.4: Pharmacoeconomic Principles & Cost-Benefit Analysis Section 3.5: Pharmacy Management, Inventory, and Operations Section 3.6: Saudi Pharmacy Law & SFDA Regulations Section 3.7: Biostatistics, Clinical Trial Design & Literature Evaluation Section 3.8: Professional Ethics, Communication, and Dispensing Systems
5 Chapter 4: Clinical Sciences
Section 4.1: Drug Information Services & Evidence-Based Medicine Section 4.2: Clinical Pharmacokinetics & Therapeutic Drug Monitoring (TDM) Section 4.3: Clinical Pharmacogenomics & Personalized Therapeutics Section 4.4: Disease Prevention, Wellness, and Immunization Schedules Section 4.5: Patient Assessment & Physical Examination Interpretation Section 4.6: Clinical Pharmacology: Cardiovascular Disorders Section 4.7: Clinical Pharmacology: Renal & Urological Disorders Section 4.8: Clinical Pharmacology: Respiratory & Pulmonary Disorders Section 4.9: Clinical Pharmacology: Endocrine & Metabolic Disorders Section 4.10: Clinical Pharmacology: Infectious Diseases & Antimicrobial Stewardship Section 4.11: Clinical Pharmacology: Neurological & Psychiatric Disorders Section 4.12: Clinical Pharmacology: Oncology, Immunology, and Hematology Section 4.13: Clinical Pharmacology: Gastrointestinal & Hepatic Disorders Section 4.14: Therapeutic Decision-Making in Special Populations (Geriatrics, Pediatrics, Pregnancy, Lactation)
Section 2.5: Pharmacognosy: Natural Products & Dietary Supplements
Key Takeaways Explain This Topic AI
Digoxin is derived from Digitalis lanata and inhibits Na+/K+-ATPase; atropine is derived from Atropa belladonna and acts as a muscarinic antagonist.
Paclitaxel is derived from Taxus brevifolia and stabilizes tubulin polymers to prevent mitotic spindle disassembly during mitosis.
St. John's Wort is a strong inducer of CYP3A4 and P-gp, leading to critical therapeutic failure of cyclosporine and oral contraceptives.
Ginkgo biloba inhibits platelet-activating factor (PAF), synergistically increasing bleeding risks when combined with anticoagulants.
Ginseng has active ginsenosides that increase insulin release, raising hypoglycemia risk when used with antidiabetic drugs.
Last updated: July 2026
- Section 2.5: Pharmacognosy: Natural Products & Dietary Supplements
- Introduction to Pharmacognosy and Phytotherapy
Pharmacognosy is the study of physical, chemical, biochemical, and biological properties of drugs, drug substances, or potential drugs of natural origin. Many essential modern pharmaceuticals are derived directly from natural plant sources. Furthermore, herbal dietary supplements are highly popular in Saudi Arabia. The Saudi Food and Drug Authority (SFDA) regulates these products as health products, ensuring they meet standards of safety and quality. Pharmacists must understand the origin and mechanisms of major natural pharmaceuticals, as well as the safety profiles, drug interactions, and clinical counseling points for common herbal supplements.
Major Plant-Derived Pharmaceuticals
Several critical medications in modern pharmacotherapy are natural products or semi-synthetic derivatives:
Digoxin: A cardiac glycoside derived from the dried leaves of the woolly foxglove ( Digitalis lanata ). Structurally, it consists of a steroid nucleus, an unsaturated lactone ring at the C-17 position, and three sugar (digitoxose) molecules. It acts as a positive inotrope by inhibiting the cardiac N a + / K + Na^+/K^+ N a + / K + -ATPase pump, and as a negative chronotrope by enhancing vagal tone.
Atropine: A tropane alkaloid isolated from Atropa belladonna (deadly nightshade). It is a competitive antagonist of muscarinic acetylcholine receptors ( M 1 − M 5 M_1 - M_5 M 1 − M 5 ). It is used clinically as a mydriatic, to treat severe bradycardia, and as an antidote for acetylcholinesterase inhibitor toxicity (e.g., organophosphates).
Paclitaxel: A complex taxane diterpenoid originally isolated from the bark of the Pacific yew tree ( Taxus brevifolia ). Unlike other tubulin-targeting chemotherapeutics (like vinca alkaloids, which inhibit microtubule assembly), paclitaxel binds to the beta-subunit of tubulin and stabilizes microtubules , preventing their disassembly. This freezes the mitotic spindle, preventing cancer cells from dividing during mitosis (specifically in the G2/M phase) and triggering apoptosis.
- Efficacy, Safety, and Quality Control of Common Herbals
- Ginkgo Biloba
Common Use: Used to improve cognitive function, memory, dementia symptoms, and peripheral arterial disease (claudication).
Active Constituents: Flavonoids (antioxidant properties) and terpene lactones (ginkgolides and bilobalide).
Mechanism: Improves microcirculation and decreases capillary permeability. It acts as a potent antagonist of platelet-activating factor (PAF) .
Adverse Effects: Headache, GI distress, dizziness.
Clinical Warning: By inhibiting PAF, Ginkgo significantly increases the risk of bleeding. It is contraindicated in patients taking anticoagulants (e.g., warfarin, dabigatran) or antiplatelets (e.g., aspirin, clopidogrel).
St. John's Wort ( Hypericum perforatum )
Common Use: Used for mild-to-moderate depression and anxiety.
Active Constituents: Hypericin and hyperforin.
Mechanism: Inhibits the reuptake of serotonin, norepinephrine, and dopamine.
Adverse Effects: Photosensitivity, dry mouth, headache, GI upset.
Clinical Warning (The "Interactions King"): Hyperforin activates the Pregnane X Receptor (PXR), leading to a massive induction of CYP3A4, CYP2C9, CYP1A2, and P-glycoprotein . It is responsible for critical drug failures:
Immunosuppressants: Rapidly clears cyclosporine and tacrolimus, leading to acute organ transplant rejection.
Oral Contraceptives: Decreases estrogen levels, leading to breakthrough bleeding and contraceptive failure.
Anticoagulants: Accelerates metabolism of warfarin, lowering INR and increasing stroke risk.
Serotonergic Drugs: Co-administration with SSRIs, SNRIs, or MAOIs can cause life-threatening serotonin syndrome due to synergistic increases in synaptic serotonin.
Ginseng ( Panax ginseng )
Common Use: Used as an adaptogen to improve physical endurance, cognitive performance, immune function, and stress relief.
Active Constituents: Ginsenosides (triterpene saponins).
Mechanism: Modulates the hypothalamic-pituitary-adrenal axis and stimulates nitric oxide production.
Adverse Effects: Insomnia, headache, hypertension, breast tenderness, and vaginal bleeding (due to mild estrogenic effects).
Clinical Warning: Ginseng has hypoglycemic properties. It stimulates insulin release and increases glucose uptake. When used alongside antidiabetic drugs (sulfonylureas, insulin), it can cause severe hypoglycemia. It also inhibits platelet aggregation and can interact with warfarin, decreasing its anticoagulant efficacy.
- Herbal Supplement Primary Use Active Constituent Key Mechanism Major Safety Concern / Interaction
- Ginkgo Biloba Memory, Dementia Ginkgolides Antagonizes PAF Increased bleeding risk; avoid with anticoagulants
St. John's Wort Mild Depression Hyperforin, Hypericin Serotonin reuptake inhibitor Strong CYP3A4 & P-gp inducer; causes Serotonin Syndrome
Ginseng Adaptogen, Energy Ginsenosides Nitric oxide & HPA modulation Hypoglycemia risk; estrogenic effects (insomnia)
Regulatory Role of the SFDA in Herbal Products
The Saudi Food and Drug Authority (SFDA) oversees the registration and marketing of herbal products and health supplements. Under SFDA guidelines:
Herbal products must be registered before marketing and must be manufactured under Good Manufacturing Practices (GMP).
Labeling must state that the product is a health supplement and cannot claim to diagnose, treat, or cure specific diseases unless supported by extensive clinical evidence.
Standardization is required: products must state the concentration of active marker compounds (e.g., "Ginkgo extract standardized to 24% ginkgo flavone glycosides").
Heavy metal limits, pesticide residues, and microbiological contamination thresholds are strictly enforced to protect public health in the Kingdom.